Invesco
LYRA

Invesco’s LYRA THERAPEUTICS INC LYRA Stock Holding History

Invesco’s Portfolio LYRA Stock Details LYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-473
Closed -$2.98K – 3823
2025
Q1 		$2.98K Hold
473
– – ﹤0.01% 3766
2024
Q4 		$4.88K Buy
473
+20
+4% +$220 ﹤0.01% 3755
2024
Q3 		$5.82K Sell
453
-3
-0.7% -$44 ﹤0.01% 3749
2024
Q2 		$6.32K Sell
456
-10,649
-96% -$1.2M ﹤0.01% 3867
2024
Q1 		$3.45M Buy
+11,105
New +$2.96M ﹤0.01% 2428
2020
Q4 		– Sell
-3,956
Closed -$2.21M – 3800
2020
Q3 		$2.21M Sell
3,956
-62
-2% -$38.6K ﹤0.01% 2440
2020
Q2 		$2.28M Buy
+4,018
New +$2.94M ﹤0.01% 2408

Other funds holding LYRA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco's LYRA Position: Q2 2025 in Review

Invesco sold out of LYRA THERAPEUTICS INC (LYRA) in Q2 2025, closing a stake of 473 shares — an estimated $2.98K sold.

Invesco first reported a position in LYRA in Q2 2020 and held it in 7 quarters. The position peaked at $3.45M in Q1 2024. 30 funds tracked by Wall St. Rank hold LYRA as of Q2 2025.

  • Invesco reported no remaining LYRA THERAPEUTICS INC position as of Q2 2025 after selling out during the quarter.
  • Invesco sold 473 LYRA THERAPEUTICS INC shares in Q2 2025, an estimated $2.98K.
  • Invesco first reported a position in LYRA THERAPEUTICS INC in Q2 2020 and held it in 7 quarters.
  • Invesco's LYRA THERAPEUTICS INC position peaked at $3.45M in Q1 2024.
  • 30 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q2 2025.

Based on Invesco's 13F filing for Q2 2025, filed 13 Aug 2025.